Abeona Therapeutics Inc (FRA:PCJ)
€ 6.3 0.45 (7.69%) Market Cap: 248.06 Mil Enterprise Value: 154.68 Mil PE Ratio: 0 PB Ratio: 3.47 GF Score: 41/100

Q1 2023 Abeona Therapeutics Inc Earnings Call and Portfolio Update Conference Call Transcript

May 24, 2023 / 12:30PM GMT
Release Date Price: €2.86 (+2.43%)
Operator

Greetings. Welcome to the Abeona Therapeutics First Quarter '23 Portfolio Update Conference Call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host, Greg Gin, Vice President of Investor Relations and Corporate Communications. You may begin.

Gregory Gin
Abeona Therapeutics Inc. - VP of IR & Corporate Communications

Thank you, Holly. Good morning, everyone. I would like to welcome and thank everyone for joining us on our portfolio update conference call. Our objective today is to share additional new positive data from our EB-101 and AAV ophthalmology programs recently presented at scientific congresses. The press release is announcing the data at the ISID and ASGCT meetings are available on our website at www.abeonatherapeutics.com. Before we start, I would like to note that remarks made during today's call may contain projections and forward-looking statements.

Forward-looking statements are made

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot